Mucosal IgA is important for protection against respiratory infections2, and we found that proportions of IgA plasma cells were increased in coronavirus disease 2019 (COVID-19) patients versus healthy controls in single-cell data from published nasal, tracheal and bronchial brush samples (Methods) (Fig. 4h)71. This evidence concerns the gene CD79A and COVID-19.